Open access · CC-BY
via OpenAlex
Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans
Yi Zhun Zhu, Larissa G. P. Langhi Prata, Erin O. Wissler Gerdes, Jair Machado Espíndola‐Netto, Tamar Pirtskhalava, Nino Giorgadze, Utkarsh Tripathi, Christina L. Inman, Kurt O. Johnson, Ailing Xue, Allyson K. Palmer, Tingjun Chen, Kalli K. Schaefer, Jamie Nicole Justice, Anoop M. Nambiar
EBioMedicine · 2022 · ▲ 97 citations
Abstract
BACKGROUND: α-Klotho is a geroprotective protein that can attenuate or alleviate deleterious changes with ageing and disease. Declines in α-Klotho play a role in the pathophysiology of multiple diseases and age-related phenotypes. Pre-clinical evidence suggests that boosting α-Klotho holds therapeutic potential. However, readily clinically-translatable, practical strategies for increasing α-Klotho are not at hand. Here, we report that orally-active, clinically-translatable senolytics(definition) can increase α-Klotho in mice and humans. METHODS: We examined α-Klotho expression in three different human primary cell types co-cultured with conditioned medium (CM) from senescent or non-senescent cells with or without neutralizing antibodies. We assessed α-Klotho expression in aged, obese, and senescent cell-transplanted mice treated with vehicle or senolytics. We assayed urinary α-Klotho in patients with idiopathic pulmonary fibrosis (IPF) who were treated with the senolytic drug combination, Dasatinib plus Quercetin (D+Q). FINDINGS: We found exposure to the senescent cell secretome reduces α-Klotho in multiple nonsenescent human cell types. This was partially prevented by neutralizing antibodies against the senescence(definition)-associated secretory phenotype (SASP) factors, activin A and Interleukin 1α (IL-1α). Consistent with senescent cells' being a cause of decreased α-Klotho, transplanting senescent cells into younger mice reduced brain and urine α-Klotho. Selectively removing senescent cells genetically or pharmacologically increased α-Klotho in urine, kidney, and brain of mice with increased senescent cell burden, including naturally-aged, diet-induced obese (DIO), or senescent cell-transplanted mice. D+Q increased α-Klotho in urine of patients with IPF, a disease linked to cellular senescence. INTERPRETATION: Senescent cells cause reduced α-Klotho, partially due to their production of activin A and IL-1α. Targeting senescent cells boosts α-Klotho in mice and humans. Thus, clearing senescent cells restores α-Klotho, potentially opening a novel, translationally-feasible avenue for developing orally-active small molecule, α-Klotho-enhancing clinical interventions. Furthermore, urinary α-Klotho may prove to be a useful test for following treatments in senolytic clinical trials. FUNDING: This work was supported by National Institute of Health grants AG013925 (J.L.K.), AG062413 (J.L.K., S.K.), AG044271 (N.M.), AG013319 (N.M.), and the Translational Geroscience Network (AG061456: J.L.K., T.T., N.M., S.B.K., S.K.), Robert and Arlene Kogod (J.L.K.), the Connor Group (J.L.K.), Robert J. and Theresa W. Ryan (J.L.K.), and the Noaber Foundation (J.L.K.). The previous IPF clinical trial was supported by the Claude D. Pepper Older Americans Independence Centers at WFSM (AG021332: J.N.J., S.B.K.), UTHSCA (AG044271: A.M.N.), and the Translational Geroscience Network.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.ebiom.2022.103912
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Zhu, Y.Z., Prata, L.G.P.L., Gerdes, E.O.W., Espíndola‐Netto, J.M., Pirtskhalava, T., Giorgadze, N., Tripathi, U., Inman, C.L., Johnson, K.O., Xue, A., Palmer, A.K., Chen, T., Schaefer, K.K., Justice, J.N., Nambiar, A.M., Musi, N., Kritchevsky, S.B., Chen, J., Khosla, S., & Jurk, D. (2022). Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans. <em>EBioMedicine</em>. https://doi.org/10.1016/j.ebiom.2022.103912
Vancouver
Zhu YZ, Prata LGPL, Gerdes EOW, Espíndola‐Netto JM, Pirtskhalava T, Giorgadze N, et al. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans. EBioMedicine. 2022. doi:10.1016/j.ebiom.2022.103912.
BibTeX
@article{yi2022Orally,
title = {Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans},
author = {Yi Zhun Zhu and Larissa G. P. Langhi Prata and Erin O. Wissler Gerdes and Jair Machado Espíndola‐Netto and Tamar Pirtskhalava and Nino Giorgadze and Utkarsh Tripathi and Christina L. Inman and Kurt O. Johnson and Ailing Xue and Allyson K. Palmer and Tingjun Chen and Kalli K. Schaefer and Jamie Nicole Justice and Anoop M. Nambiar and Nicolas Musi and Stephen B. Kritchevsky and Jun Chen and Sundeep Khosla and Diana Jurk and Marissa J. Schafer and Tamar Tchkonia and James L. Kirkland},
journal = {EBioMedicine},
year = {2022},
doi = {10.1016/j.ebiom.2022.103912},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Innovation in Aging 2022
Open access · CC-BY
ORALLY ACTIVE, CLINICALLY TRANSLATABLE SENOLYTICS RESTORE Α-KLOTHO IN MICE AND HUMANS
Cell Proliferation 2022
Open access · CC-BY
Senescent cells: A therapeutic target for osteoporosis
JBMR Plus 2026
Open access · CC-BY
Inflammatory cytokines secreted from senescent periodontal ligament cells influence the osteocyte network in alveolar bone
Aging 2023
Open access · CC-BY
Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic
BMB Reports 2019
Open access · CC-BY
Cellular senescence in cancer
Open Biology 2022
Open access · CC-BY